Yahoo France Recherche Web

Résultats de recherche

  1. Il y a 4 jours · Comment porter et où mettre ses bâtons de trail running quand on court et qu'on ne les utilisent pas ? Carquois, ceinture porte-bâtons, sac, découvrons quelles sont les différentes solutions de portage des bâtons pliables ou télescopiques pendant la course à pied.

  2. Il y a 2 jours · All corporate executive members have opportunities to hear distinguished speakers, such as overseas presidents and prime ministers, chairs and CEOs of multinational corporations, and U.S. officials and Congressmen.

  3. Il y a 3 jours · Sessions. 1st: January 4, 1995 – January 3, 1996 2nd: January 3, 1996 – October 4, 1996. The 104th United States Congress was a meeting of the legislative branch of the United States federal government, composed of the United States Senate and the United States House of Representatives.

  4. Il y a 5 jours · A must read " --Porter Goss, former director of the Central Intelligence Agency on The Persian Gamble. In the follow-up to the New York Times bestselling Kremlin Conspiracy, Rosenberg's latest international thriller tracks a terrifying nuclear alliance among three world powersRussia, Iran, and North Koreaand the deadly mission former US Secret ...

  5. Il y a 4 jours · En ce mois de juillet, alors que les regards du monde entier se porteront sur la parade fluviale des Jeux Olympiques à Paris, il s'agira de nous allier pour remporter la plus essentielle des épreuves : trouver les gestes collectifs pour que l’eau soit enfin protégée dans ce pays et partout ailleurs.

  6. Il y a 2 jours · Porter Goss : Republican: January 3, 1989 – January 3, 1993 101st 102nd: Elected in 1988. Re-elected in 1990. Redistricted to the 14th district. Dan Miller : Republican: January 3, 1993 – January 3, 2003 103rd 104th 105th 106th 107th: Elected in 1992. Re-elected in 1994. Re-elected in 1996. Re-elected in 1998. Re-elected in 2000. Retired ...

  7. Il y a 3 jours · GOSS Stock Overview. A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. About the company. GOSS fundamental analysis.